Kalincik, T. Et Al. 2014. Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis. Joint ACTRIMS-ECTRIMS Meeting , (Massachusetts, United States Of America), 195-196.

Kalincik, T., Horakova, D., Spelman, T., Jokubaitis, V., Trojano, M., Lugaresi, A., ... Izquierdo, G.(2014). Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis . Joint ACTRIMS-ECTRIMS Meeting (pp.195-196). Massachusetts, United States Of America

Kalincik, T. Et Al. "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis," Joint ACTRIMS-ECTRIMS Meeting, Massachusetts, United States Of America, 2014

Kalincik, T. Et Al. "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis." Joint ACTRIMS-ECTRIMS Meeting , Massachusetts, United States Of America, pp.195-196, 2014

Kalincik, T. Et Al. (2014) . "Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis." Joint ACTRIMS-ECTRIMS Meeting , Massachusetts, United States Of America, pp.195-196.

@conferencepaper{conferencepaper, author={T. Kalincik Et Al. }, title={Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis}, congress name={Joint ACTRIMS-ECTRIMS Meeting}, city={Massachusetts}, country={United States Of America}, year={2014}, pages={195-196} }